Market Exclusive

Analyst Activity – Piper Jaffray Companies Reiterates Overweight on NASDAQ:EIGR – Eiger Biopharmaceuticals (NASDAQ:EIGR)

Analyst Ratings For NASDAQ:EIGR – Eiger Biopharmaceuticals (NASDAQ:EIGR)

Today, Piper Jaffray Companies reiterated its Overweight rating on NASDAQ:EIGR – Eiger Biopharmaceuticals (NASDAQ:EIGR) with a price target of $24.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:EIGR – Eiger Biopharmaceuticals (NASDAQ:EIGR)
NASDAQ:EIGR – Eiger Biopharmaceuticals (NASDAQ:EIGR) has insider ownership of 7.90% and institutional ownership of 65.92%.

Recent Trading Activity for NASDAQ:EIGR – Eiger Biopharmaceuticals (NASDAQ:EIGR)
Shares of NASDAQ:EIGR – Eiger Biopharmaceuticals closed the previous trading session at 13.68 up +0.13 0.92% with 24007 shares trading hands.

Exit mobile version